Physician

Richard A Bazarian, MD

According to 2025 Medicare claims, Richard Bazarian, MD (NPI: 1891791455) practices ophthalmology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Cumberland, ME. This provider's primary affiliated billing organization is MAINE EYE CENTER, PA (NPI: 1720044878; TIN: 01-0329291) and primary practice location at 04101-2438. Bazarian is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Bazarian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 510 traditional Medicare patients, billed 21,945 HCPCS/CPT codes, and received $2,182,281 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 393 prescription claims across 157 beneficiaries totaling $18,490 in drug costs, led by Tobramycin-Dexamethasone (Tobramycin/Dexamethasone). Open Payments data shows 3 records totaling $55. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2015 Medicare payment: $2,904,668 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,123,469 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,905,732 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,432,619 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,501,755 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,333,370 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,597,992 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,254,722 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,368,060 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,182,281 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201584811,135$2,904,668
201692212,627$3,123,469
201786010,717$2,905,732
20187528,939$2,432,619
20197558,501$2,501,755
20206727,249$2,333,370
20217438,461$2,597,992
20226818,320$2,254,722
202356217,377$2,368,060
202451021,945$2,182,281

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$41K2015 Drug cost: $15,245 (USD; Tot_Drug_Cst)2016 Drug cost: $26,980 (USD; Tot_Drug_Cst)2017 Drug cost: $39,371 (USD; Tot_Drug_Cst)2018 Drug cost: $40,551 (USD; Tot_Drug_Cst)2019 Drug cost: $35,306 (USD; Tot_Drug_Cst)2020 Drug cost: $34,930 (USD; Tot_Drug_Cst)2021 Drug cost: $37,601 (USD; Tot_Drug_Cst)2022 Drug cost: $29,005 (USD; Tot_Drug_Cst)2023 Drug cost: $23,878 (USD; Tot_Drug_Cst)2024 Drug cost: $18,490 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201556136$15,245
201667198$26,980
201773284$39,371
2018117349$40,551
2019146416$35,306
2020136385$34,930
2021178441$37,601
2022142397$29,005
2023147407$23,878
2024157393$18,490

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1781,728$652
67028Injection of drug into eye2451,119$105
92014Established patient complete exam of visual system423708$98
92134Imaging of retina4541,213$33
92250Photography of the retina105120$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tobramycin-DexamethasoneTobramycin/Dexamethasone1322,836$5,181
Prednisolone AcetatePrednisolone Acetate1003,589$4,213
Ketorolac TromethamineKetorolac Tromethamine812,674$2,863
DifluprednateDifluprednate14432$1,206

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$55ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.1$8,518US Retina LLC

FAQ

What Medicare data is available for Richard A. Bazarian, MD?

Tedicare shows public-source Medicare data for Richard A. Bazarian, MD (NPI 1891791455), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard A. Bazarian, MD have ACO affiliation data?

Richard A. Bazarian, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Richard A. Bazarian, MD?

Richard A. Bazarian, MD is linked to MAINE EYE CENTER, PA (billing NPI 1720044878) in the available physician profile data.

Does Richard A. Bazarian, MD have Open Payments data?

Richard A. Bazarian, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.